Russian Vaccine Sputnik V is 91.6% Effective Against COVID-19
India is going to approve the Russian vaccine Sputnik V which is said to be over 91.6% effective based on late-stage trials in Russia. The results were published in The Lancet medical journal recently.
Indians are being vaccinated with the Covishield vaccine from the Serum Institute, a formula developed by Oxford, and the vaccine named Covaxin, a joint venture between Bharat Biotech and ICMR. Both these vaccines were given approval in the Indian market.
Dr. Reddy’s Laboratory, a Hyderabad-based vaccine manufacturer, is conducting a trial of Russia’s Sputnik V vaccine among foreign vaccines. According to the company, the results of this vaccine trial are quite good. The Sputnik V vaccine will be available in the country from March to April, and the vaccine will be sold to the government at a lower price.
Dr. Deepak Sapra, Senior Vice President of Dr. Reddy’s Laboratories Ltd., said that mass vaccinations would begin as soon as the people of the country were sure that the Sputnik vaccine was safe and secure. Reports of each stage of the trial will be submitted to the Central Drug Regulatory Authority. Dr. Sapra told that there have been no problems with the vaccine trial so far.
The Sputnik vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology of Russia. An agreement has been signed with Dr. Reddy’s Laboratory for the production and distribution of this vaccine in India under the supervision of the Russian Direct Investment Fund (RDIF). Gamaleya has signed a contract for a dose of around Rs 200 million in the first phase. A joint statement from RDIF and Dr. Reddy’s said that safety and controlled trials of the vaccine were being conducted in India.
A small number of volunteers were monitored with a dose of the Sputnik V vaccine. G V Prasad, Co-Chairman and Managing Director of Dr. Reddy’s Lab, told that safety has been verified before applying the Sputnik V vaccine. Safety trial reports will be submitted in each phase.
Click to read more at https://www.bigumbrella.co.in/russian-vaccine-sputnik-v-is-91-6-effective-against-covid-19/